- R D-Driven and AI-Powered Biopharma Company | Sanofi
Sanofi is a research development-driven, AI-powered healthcare biopharma company committed to improving lives through innovative medicines vaccines
- Sanofi Pharmaceuticals - Healthcare Innovations | Sanofi USA
Discover how Sanofi, a global pharmaceutical company, is shaping healthcare in the US with innovative solutions and treatments
- Sanofi - Wikipedia
Sanofi engages in the research and development, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications
- Sanofi to invest at least $20 billion in the US through 2030 . . .
"Sanofi's 13,000 US-based employees are pioneering the research and development of first- and best-in-class medicines across numerous therapeutic areas Our expected investments in the US will be substantial and will help ensure the production of key medicines in the US "
- Our Company: Committed to Improving Peoples Lifes | Sanofi
We are an R D driven, AI-powered biopharma company committed to improving people’s lives and creating compelling growth Our team is guided by one purpose: we chase the miracles of science to improve people’s lives We want to build a healthier, more resilient world
- Sanofi tightens grip on RSV, paying $1. 15B upfront for . . .
Sanofi has struck a deal to buy Vicebio for $1 15 billion upfront, securing preclinical and phase 1 vaccine candidates to expand its respiratory syncytial virus (RSV) pipeline beyond mRNA The
- Our Company - Sanofi U. S.
Learn about Sanofi, a leading global pharmaceutical company in the US, advancing specialty care, vaccines, and consumer healthcare
- Frances Sanofi to acquire biotech firm Vicebio for $1. 15 . . .
French pharmaceuticals company Sanofi said on Tuesday it would acquire British private biotechnology firm Vicebio for a total of $1 15 billion, expanding its respiratory vaccine portfolio
|